Russell Anderson

Russell counsels companies through a broad range of domestic and cross-border M&A and venture capital transactions with a focus on the tech and life sciences sectors. Russell was previously seconded to a major financial institution where he advised on a number of asset sales and corporate governance issues as part of the EMEA consumer legal team. He is a co-chair of the firm’s LGBTQ+ Affinity Group and a member of the firm's pro bono committee.

His recent experience includes advising:

• EsoBiotec on its sale to AstraZeneca for up to $1 billion
• Amryt Pharma on its sale to Chiesi Farmaceutici for $1.48 billion
• GeBBS Healthcare Solutions on its sale to EQT Private Capital Asia
• Neurocrine Biosciences on the sale of Neurocrine Group to Immedica
• Redx Pharma, a UK clinical-stage biotechnology company, on its all-share merger with Jounce Therapeutics, a US clinical-stage immunotherapy company, in a $425 million and contingent value right transaction
• Ieso Digital Health on the sale of Ieso Digital Health UK to Mindler
• Karo Pharma on its acquisition of the E45 brand from Reckitt
• HitGen on its acquisition of research company Vernalis Research (R&D) from Ligand Pharmaceuticals
• Tusk Therapeutics, a UK immuno-oncology company, on its sale to Roche for up to $759 million
• Neurocrine Biosciences on its acquisition of Diurnal Group
• Alvotech Holdings, a global biopharmaceutical company, on its combination with special purpose acquisition company (SPAC) Oaktree Acquisition Corp. II, with the combined company valued at $2.25 billion
• Guardsquare on its sale to Verdane
• UiPath on its acquisition of Peak
• UiPath on its acquisition of Re:infer
• Brainlabs on its sale to and investment from Falfurrias Capital Partners
• Madison Bidco on the take-private of Velocys
• Chegg in connection with its acquisition of Busuu for approximately $436 million
• Brandwatch, a global leader in digital consumer intelligence and social media listening, on its agreement to sell to Cision for $450 million
• Brandwatch on its acquisition of Paladin, a comprehensive influencer marketing platform
• Cision, a global comprehensive communications platform, on its acquisition of Factmata, an advanced social and news media monitoring company
• Cisco on its bolt-on acquisition of Ensoft, a specialist in developing network software
• DocuSign on its $188 million acquisition of Seal Software
• Luna Innovations, a developer of fibre optic-based technologies, on its acquisition of Silixa
• Luna Innovations on its acquisition of OptaSense from QinetiQ
• AAC Clyde Space on its acquisition of SpaceQuest, a satellite technology developer based in Virginia
• Adestra, a provider of email, marketing and transaction automation software, on its sale to Upland Software for $56 million
• Style Analytics, a factor and ESG exposure analytics provider, on its sale to Investment Metrics

Pro bono

Russell regularly advises not-for profits and charities on corporate governance issues.